Style | Citing Format |
---|---|
MLA | Dejban P, et al.. "The Role of Medicinal Products in the Treatment of Inflammatory Bowel Diseases (Ibd) Through Inhibition of Tlr4/Nf-Kappab Pathway." Phytotherapy Research, vol. 35, no. 2, 2021, pp. 835-845. |
APA | Dejban P, Nikravangolsefid N, Chamanara M, Dehpour A, Rashidian A (2021). The Role of Medicinal Products in the Treatment of Inflammatory Bowel Diseases (Ibd) Through Inhibition of Tlr4/Nf-Kappab Pathway. Phytotherapy Research, 35(2), 835-845. |
Chicago | Dejban P, Nikravangolsefid N, Chamanara M, Dehpour A, Rashidian A. "The Role of Medicinal Products in the Treatment of Inflammatory Bowel Diseases (Ibd) Through Inhibition of Tlr4/Nf-Kappab Pathway." Phytotherapy Research 35, no. 2 (2021): 835-845. |
Harvard | Dejban P et al. (2021) 'The Role of Medicinal Products in the Treatment of Inflammatory Bowel Diseases (Ibd) Through Inhibition of Tlr4/Nf-Kappab Pathway', Phytotherapy Research, 35(2), pp. 835-845. |
Vancouver | Dejban P, Nikravangolsefid N, Chamanara M, Dehpour A, Rashidian A. The Role of Medicinal Products in the Treatment of Inflammatory Bowel Diseases (Ibd) Through Inhibition of Tlr4/Nf-Kappab Pathway. Phytotherapy Research. 2021;35(2):835-845. |
BibTex | @article{ author = {Dejban P and Nikravangolsefid N and Chamanara M and Dehpour A and Rashidian A}, title = {The Role of Medicinal Products in the Treatment of Inflammatory Bowel Diseases (Ibd) Through Inhibition of Tlr4/Nf-Kappab Pathway}, journal = {Phytotherapy Research}, volume = {35}, number = {2}, pages = {835-845}, year = {2021} } |
RIS | TY - JOUR AU - Dejban P AU - Nikravangolsefid N AU - Chamanara M AU - Dehpour A AU - Rashidian A TI - The Role of Medicinal Products in the Treatment of Inflammatory Bowel Diseases (Ibd) Through Inhibition of Tlr4/Nf-Kappab Pathway JO - Phytotherapy Research VL - 35 IS - 2 SP - 835 EP - 845 PY - 2021 ER - |